“…26 However, a Cochrane Review of interventions designed to enhance partner support for smokers in cessation programs concluded that such interventions did not increase quit rates. 27 Another view of the positive effect of marriage on cigarette smoking is the development of a more responsible concern with lifestyle and health. 28 In particular, increased personal commitment to a spouse and preparation for parenthood (i.e.…”
Life changes such as marriage and actual or contemplated pregnancy provide opportunities for targeted interventions to help women quit smoking and not relapse after having a baby. Legislation to control smoking on licensed premises would reduce the social pressure on women to smoke.
“…26 However, a Cochrane Review of interventions designed to enhance partner support for smokers in cessation programs concluded that such interventions did not increase quit rates. 27 Another view of the positive effect of marriage on cigarette smoking is the development of a more responsible concern with lifestyle and health. 28 In particular, increased personal commitment to a spouse and preparation for parenthood (i.e.…”
Life changes such as marriage and actual or contemplated pregnancy provide opportunities for targeted interventions to help women quit smoking and not relapse after having a baby. Legislation to control smoking on licensed premises would reduce the social pressure on women to smoke.
“…In fact, despite some evidence that support is associated with smoking abstinence (Coppotelli & Orleans, 1985;Gulliver, Hughes, Soloman, & Dey, 1995;Mermelstein, Cohen, Lichtenstein, Baer, & Kamarck, 1986), many interventions designed to enhance support for smoking cessation have failed to achieve desired results (Park, Schultz, Tudiver, Campbell, & Becker, 2008). To inform the development of smoking cessation interventions that attempt to capitalize on the potential benefits of close personal relationships, it is critical to understand the mechanisms underlying effective support for cessation (Westmaas, Bontemps-Jones, & Baueret, 2010).…”
Introduction: Smoking cessation research has demonstrated a link between social support and quitting, but interventions designed to enhance partner support have often failed. We adapted and tested a measure of dyadic efficacy to assess smokers' confidence in their abilities to work together as a team with their partners to quit smoking and cope with quitting challenges. Our goal was to establish the psychometric properties of the dyadic efficacy instrument, including its associations with cessation outcomes.
Methods:We recruited partnered smokers who called the American Cancer Society's Quitline and administered telephone interviews (N = 634, 59% female, average age = 40 years). Interviews included 8 dyadic efficacy items and a variety of sociodemographic, smoking history, and relationship variables at baseline and quit outcomes at 4 months.Results: Factor analysis of the dyadic efficacy items yielded a 1-factor scale with strong internal consistency (a = .92). Dyadic efficacy was positively associated (p < .0001) with smoking-specific support (r = .51), relationship satisfaction (r = .44), and dyadic coping (r = .54). Dyadic efficacy was not associated with age, gender, race, relationship length, smoking quantity, or previous quit attempts. Respondents with smoking partners who were willing to quit with them had higher dyadic efficacy than those whose smoking partners were not (p < .0001). Higher baseline dyadic efficacy was predictive of 7-day point prevalence quit rates at follow-up (odds ratio = 1.25, 95% CI = 1.02-1.53).
Conclusions:With further study, dyadic efficacy may enhance our understanding of the role of partner relationships in smoking cessation.
“…Choosing a person who is a current smoker as a support partner is related to relapse. 6,11 Addiction and the effect of nicotine on the dopamine reward pathway of the brain have been well described 12 and are important concepts for healthcare clinicians to appreciate. The desire of men and women to take drugs has a biological basis that is the result of a fluctuation in the levels of the brain chemical dopamine.…”
Smoking and obesity are widely recognized cardiovascular risk factors for significant morbidity and mortality in women. Although women still smoke less than men do, smoking among women is on the increase, especially in younger women and teenagers. Reduction of cardiovascular risk through smoking cessation while maintaining weight is a major goal of intervention. The purpose of this article is to discuss best care practices for women with tobacco addiction using a 3-point integration of clinical expertise, the best available evidence gained from systematic research, and an analysis of satisfaction with care data. A model for a smoking cessation intervention with weight management content is presented using a conceptual framework of social learning theory, self-efficacy judgments, and the 4 principal sources of self-efficacy information. The specific aims of this pilot study are to (1) test the feasibility of the study methods and procedures, including subject accrual, attrition, and reliability of the instruments and protocol; (2) explore utilization of and satisfaction with the intervention; and (3) describe the impact of the intervention on primary (smoking biomarker) and secondary (weight/body mass index, depression, partner support, and smoking cessation self-efficacy temptations) outcomes. Results show that the study is feasible, but modifications are needed to improve utilization and satisfaction with care. The primary outcome showed a reduction in the smoking biomarker while maintaining weight at the 2-month follow-up. There was also improvement in skills to manage temptation situations that supported the conceptual framework. Hypotheses are presented for a future experimental study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.